These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33832088)

  • 41. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
    Na CJ; Jeong YJ; Lim ST; Sohn MH; Jeong HJ
    Clin Nucl Med; 2016 Feb; 41(2):e104-6. PubMed ID: 26545025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
    Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
    Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adult-onset opsoclonus-myoclonus syndrome.
    Klaas JP; Ahlskog JE; Pittock SJ; Matsumoto JY; Aksamit AJ; Bartleson JD; Kumar R; McEvoy KF; McKeon A
    Arch Neurol; 2012 Dec; 69(12):1598-607. PubMed ID: 22986354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
    Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome.
    Gorman MP
    Curr Opin Pediatr; 2010 Dec; 22(6):745-50. PubMed ID: 20871403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Paraneoplastic opsoclonus myoclonus ataxia syndrome].
    Aguilera Albesa S; Botella MP; Salado C; Bosque A; Ocio I; Montiano JI
    An Sist Sanit Navar; 2009; 32(1):91-5. PubMed ID: 19430515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Opsoclonus-myoclonus syndrome: a case report].
    Jomir L; Sirvain S; Bouly S; Garrido JF; Hallé O
    Rev Med Interne; 2009 Nov; 30(11):980-1. PubMed ID: 19695745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
    Galstyan A; Wilbur C; Selby K; Hukin J
    Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review.
    Rothenberg AB; Berdon WE; D'Angio GJ; Yamashiro DJ; Cowles RA
    Pediatr Radiol; 2009 Jul; 39(7):723-6. PubMed ID: 19430769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opsoclonus-Myoclonus Syndrome in Primary Central Nervous System Lymphoma.
    Grubbs J; Trobe JD; Fisher-Hubbard A
    J Neuroophthalmol; 2016 Dec; 36(4):408-411. PubMed ID: 27023309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transient symptomatic worsening by atropine in opsoclonus-myoclonus syndrome.
    Miyoshi H; Nakamura R; Yamaga A; Haraki T; Yasuda T; Hamada H; Kawamoto M
    Pediatr Int; 2017 Jan; 59(1):97-98. PubMed ID: 28102628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.
    Bîrluţiu V; Bîrluţiu RM
    J Med Case Rep; 2014 Jun; 8():232. PubMed ID: 24968889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED
    Brain Dev; 2016 May; 38(5):439-48. PubMed ID: 26786246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome.
    Santoro JD; Kerr LM; Codden R; Casper TC; Greenberg BM; Waubant E; Kong SW; Mandl KD; Gorman MP
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34475249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scrub typhus meningoencephalitis presenting as opsoclonus myoclonus syndrome: A video-based case.
    Ramkumarsingh Tomar L; Jatinbhai Shah D; Agarwal U; Gogia A; Rohatgi A; Agrawal CS
    Trop Doct; 2022 Jan; 52(1):192-195. PubMed ID: 34355588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?
    Paliwal VK; Chandra S; Verma R; Kalita J; Misra UK
    J Neural Transm (Vienna); 2010 May; 117(5):613-5. PubMed ID: 20094737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.